Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Devyser logo — A new level of certainty

Devyser

A new level of certainty

Founded 2004 Sweden Sweden 123 employees Biotechnology, Health Care

General Information

Company Name Devyser
Founded Year 2004
Location Sweden Sweden +7
Employees 123
Industries Biotechnology, Health Care
Social

Get notified when Devyser moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Devyser

Devyser is a biotechnology startup that has the slogan "A new level of certainty." The company specializes in diagnostic kits for complex DNA testing within oncology, hereditary diseases, and transplantation. Founded in 2004, Devyser's products are used to guide targeted cancer therapies, enable rapid prenatal diagnostics, and aid in post-transplant follow-up. Their guiding principle revolves around the development of products that are ideal for routine diagnostics - making the technology simple, reproducible, and less prone to user-generated errors.

Devyser has gained recognition and trust from customers worldwide, with routine diagnostic laboratories in over 60 countries utilizing their products. The company aims to provide a new level of certainty in the field of genetic testing and diagnostics, and its focus on precision and reliability is evident in its widespread adoption within the healthcare industry.

Taxonomy: DNA diagnostic kits, Genetic testing kits, Oncology diagnostics, Hereditary diseases diagnostics, Transplantation diagnostics, Prenatal diagnostics, NGS (Next Generation Sequencing), PCR (Polymerase Chain Reaction), QF-PCR (Quantitative Fluorescent Polymerase Chain Reaction), Multiplex PCR, Targeted NGS resequencing, In vitro diagnostics, Reproductive Health, Cancer diagnostics

No funding data available for Devyser yet.

Get notified when Devyser raises funding

Devyser Alternatives & Competitors

Devyser vs
Roche
Roche Switzerland

A healthy Sweden, where all knowledge is put to use.

106552 employees
Biotechnology, Health Care
Devyser vs
Co-Diagnostics, Inc
Co-Diagnostics, Inc United States

the Power to Know

IPO
88 employees
Biotechnology
Devyser vs
AdvancedSeq: Sanger Sequencing/Fragment Analysis
AdvancedSeq: Sanger Sequencing/Fragment Analysis United States

A biotech company providing Sanger Sequencing products to service companies and institutional genomi...

1 employees
E-Commerce, CRM and Sales

FAQ About Devyser

A new level of certainty
Devyser was founded in 2004.
Devyser is headquartered in Sweden.
Devyser operates in the following industries: Biotechnology, Health Care.
Devyser has approximately 123 employees.
Top alternatives and competitors to Devyser include Roche, Co-Diagnostics, Inc, AdvancedSeq: Sanger Sequencing/Fragment Analysis, KH Medical, artus. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Devyser and Roche are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Devyser and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy